A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
The Chosun Ilbo on MSN
Patients visiting hospitals over 300 times to pay 90% of costs
The out-of-pocket rate for "medical shopping" patients who receive outpatient care at hospitals over 300 times a year will ...
Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.
Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...
LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...
Kardigan(TM), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced ...
The digital model recreates RPE cells, which are vital for light-sensing photoreceptors in the retina.
Sky Victor, Betty Bayo's daughter, shares her hospital journey battling a blood infection with heartfelt prayers and support ...
Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...
Mass General Brigham researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results